(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 9. Tbx5 and Tbx20 synergistically act to regulate cardiac
gene expression. (A-L) Embryos injected with the indicated morpholinos at the
one-cell stage. (A-D) Nkx2-5 whole-mount in situ hybridization. (E-H)
XANF whole-mount in situ hybridization. (I-L) XTnIc
whole-mount in situ hybridization. (A,E,I) ControlMO, (B,F,J) TBX5MO injected
at suboptimal dose, (C,G,K) TBX20MO injected at suboptimal dose, (D,H,L)
TBX5MO and TBX20MO injected in combination at suboptimal doses. All embryo
were cleared to reveal heart expression. (M) Statistics for embryos injected
with suboptimal doses of TBX5MO and TBX20MO in combination with each other or
with ControlMO. Hearts were judged as having defects if they displayed a
pericardial edema, an unlooped heart tube or reduction in cardiac mass.